Search Within

Patricia Myskowski

Formats
  1. Journal Article (121)
  2. Meeting Abstract (73)
  3. Book Section (8)
  4. Research Letter (6)
  5. Review (5)
  6. Conference Paper (2)
  7. Correspondence (2)
  8. Editorial (2)
Groups
  1. Department of Medicine (219)
  2. Dermatology (219)
  3. Dermatology Service (219)
  4. Division of Subspecialty Medicine (219)
  5. Population Sciences Research Program (90)
  6. Department of Pathology and Laboratory Medicine (88)

More Groups

People
  1. Steven Horwitz (75)
  2. Melissa Pulitzer (60)
  3. Alison Moskowitz (58)
  4. Shamir Geller (44)
  5. Christiane Querfeld (21)
  6. Klaus Busam (21)

More People

Years
  1. 2025 (3)
  2. 2024 (3)
  3. 2023 (5)
  4. 2022 (3)
  5. 2021 (9)
  6. 2020 (11)

More Years

Publications
  1. Journal of the American Academy of Dermatology (38)
  2. Blood (25)
  3. Journal of Investigative Dermatology (13)
  4. Clinical Research (9)
  5. International Journal of Dermatology (9)
  6. Journal of Clinical Oncology (9)

More Publications

Publishers
  1. Mosby Elsevier (38)
  2. American Society of Hematology (25)
  3. Wiley Blackwell (23)
  4. Elsevier Inc. (14)
  5. Elsevier Science, Inc. (14)
  6. Lippincott Williams & Wilkins (13)

More Publishers

Results (219)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Real-world single-center experience with oral and topical JAK inhibitors in patients with cutaneous T-cell lymphoma
    Meeting Abstract

    Liao, V.; Lavin, L.; Ong, M.; Moskowitz, A.; Myskowski, P.; Geller, S.
    Journal of the American Academy of Dermatology (2025)

    Fulltext@MSK | Save
  • Oral and topical Janus kinase inhibitors in patients with cutaneous t-cell lymphoma: A real-world single-center experience
    Journal Article

    Liao, V.; Lavin, L.; Ong, M. M.; Pulitzer, M. P.; Moskowitz, A. J.; Myskowski, P. L.; Geller, S.
    Journal of Dermatology (2025)

    Fulltext@MSK | Save
  • Cutaneous T-cell lymphoma and dupilumab use: A retrospective matched cohort study of clinical characteristics and treatment outcomes
    Research Letter

    Stuver, R.; Dusza, S.; Epstein-Peterson, Z. D.; Ghione, P.; Horwitz, S. M.; Johnson, W.; Moskowitz, A. J.; Myskowski, P.; Pulitzer, M.; Geller, S.
    Journal of the European Academy of Dermatology and Venereology (2025)

    Fulltext@MSK | Save
  • Dual-targeted therapy with ruxolitinib plus duvelisib for T-cell lymphoma
    Meeting Abstract

    Moskowitz, A.; Ganesan, N.; Chang, T.; Davey, T.; Hancock, H.; Smith, M.; Assini, A.; Sarmasti, L.; Miller, T.; Gibaldi, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Characterization of skin response in patients with mycosis fungoides and sezary syndrome treated with mogamulizumab: A retrospective, real world cohort
    Meeting Abstract

    Christensen, R.; Stuver, R.; Dusza, S.; Epstein-Peterson, Z. D.; Ghione, P.; Horwitz, S.; Johnson, W. T.; Moskowitz, A.; Myskowski, P.; Pulitzer, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Racial disparities in mycosis fungoides/Sézary syndrome–A single-center observational study of 292 patients
    Journal Article

    Gandham, A. R.; Geller, S.; Dusza, S. W.; Kupper, T. S.; Myskowski, P. L.
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Cutaneous T-cell lymphoma and dupilumab use: A retrospective matched cohort study of clinical characteristics and treatment outcomes
    Meeting Abstract

    Stuver, R.; Dusza, S.; Epstein-Peterson, Z. D.; Ghione, P.; Johnson, W.; Moskowitz, A.; Myskowski, P.; Pulitzer, M.; Horwitz, S. M.; Geller, S.
    Blood (2023)

    Fulltext@MSK | Save
  • Reduced dose brentuximab vedotin for mycosis fungoides appears to prolong response duration by balancing efficacy and tolerability
    Meeting Abstract

    Munayirji, B.; Khan, N.; Myskowski, P.; Geller, S.; Noor, S.; Kheterpal, M. K.; Davey, T.; Hancock, H.; Perez, L.; Miller, T.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Racial disparities in mycosis fungoides/Sezary syndrome: An observational study of 296 patients
    Meeting Abstract

    Myskowski, P.; Gandham, A.; Geller, S.; Dusza, S.; Kupper, T.
    European Journal of Cancer (2023)

    Fulltext@MSK | Save
  • A Rare case of primary cutaneous gamma-delta T-cell lymphoma with aberrant B-cell marker expression
    Journal Article

    Trivedi, A.; Yabe, M.; Dogan, A.; Epstein-Peterson, Z. D.; Myskowski, P. L.; Arcila, M. E.; Linos, K.
    American Journal of Dermatopathology (2023)

    Fulltext@MSK | Save